Concepedia
Statistics
Publications
57
Citations
4.8K
H-Index
35
Active since
1983
Affiliations
Abbott Fund(Current)
AbbVie (United States)
Abbott (United Kingdom)
Health and Environmental Sciences Institute
Abbott (United States)
Gary A. Gintant is an author at Abbott Fund specializing in medicine, pharmacology, and electrophysiology.
Publications per year
1983–2023
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager, Gary A. Gintant, J. Rick Turner et al. · American Heart Journal · 2013 · 548 citations · Full text
Medicine, Cardiology, Pharmacology +15
Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle.
D W Liu, Gary A. Gintant, Charles Antzelevitch · Circulation Research · 1993 · 464 citations · Full text
Medicine, Cardiology, Physiology +17
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
Thomas Colatsky, Bernard Fermini, Gary A. Gintant et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 463 citations · Full text
Medicine, Cardiology, Pharmacology +17
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova, Qianyu Dang, Daniel Millard et al. · Cell Reports · 2018 · 370 citations · Full text
Medicine, Cardiology, Pharmacology +16
The Utility of hERG and Repolarization Assays in Evaluating Delayed Cardiac Repolarization: Influence of Multi-Channel Block
Ruth L. Martin, Jeff S. McDermott, Heinz J. Salmen et al. · Journal of Cardiovascular Pharmacology · 2004 · 179 citations
1–5 of 57